MedPath
NMPA Approval

Methylprednisolone Sodium Succinate for Injection

国药准字HJ20170199

Pfizer SA

December 1, 2021

H20170199

Drug Information

注射用甲泼尼龙琥珀酸钠

甲强龙

注射剂

500mg(以甲泼尼龙计)

化学药品

December 1, 2021

November 30, 2026

Company Information

Applicant Company

Pfizer SA

Boulevard de la Plaine 17, 1050 Bruxelles, Belgium

Manufacturing Company

Rijksweg 12, 2870 Puurs, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用甲泼尼龙琥珀酸钠 - NMPA 批准文号 | MedPath